442
Last Update Posted: 2011-06-20
Recruiting has ended
All Genders accepted | 18 Years-60 Years |
57 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Naltrexone for Relapse Prevention
This study is to evaluate the safety and effectiveness of an injectable slow releasing preparation of naltrexone to reduce alcohol consumption and risk of relapse in alcohol-dependent subjects. Individuals will receive either naltrexone or a placebo injection for a total of three months, with two subsequent followup visits spanning a 6- month period.
Eligibility
Relevant conditions:
Alcoholism
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov